Balancing early access with uncertainties in evidence for drugs authorized by prospective case series – systematic review of reimbursement decisions

AIMS: To review clinical and cost‐effectiveness evidence underlying reimbursement decisions relating to drugs whose authorization mainly is based on evidence from prospective case series. METHODS: A systematic review of all new drugs evaluated in 2011–2016 within a health care profession‐driven reso...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallerstedt, Susanna M., Henriksson, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980547/
https://www.ncbi.nlm.nih.gov/pubmed/29381234
http://dx.doi.org/10.1111/bcp.13531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980547/
https://www.ncbi.nlm.nih.gov/pubmed/29381234
http://dx.doi.org/10.1111/bcp.13531

Ejemplares similares